Annual Current Liabilities
$13.73 M
-$1.78 M-11.47%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual total current liabilities is $13.73 million, with the most recent change of -$1.78 million (-11.47%) on December 31, 2023.
- During the last 3 years, SLS annual current liabilities has risen by +$1.40 million (+11.34%).
- SLS annual current liabilities is now -78.01% below its all-time high of $62.47 million, reached on December 31, 2013.
Performance
SLS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$10.61 M
-$1.43 M-11.89%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly total current liabilities is $10.61 million, with the most recent change of -$1.43 million (-11.89%) on September 30, 2024.
- Over the past year, SLS quarterly current liabilities has dropped by -$3.12 million (-22.73%).
- SLS quarterly current liabilities is now -83.01% below its all-time high of $62.47 million, reached on December 31, 2013.
Performance
SLS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SLS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.5% | -22.7% |
| 3 y3 years | +11.3% | -20.9% |
| 5 y5 years | +129.9% | -20.9% |
SLS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.5% | +175.7% | -31.6% | +113.0% |
| 5 y | 5-year | -11.5% | +175.7% | -31.6% | +192.0% |
| alltime | all time | -78.0% | -100.0% | -83.0% | -100.0% |
SELLAS Life Sciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.61 M(-11.9%) |
| Jun 2024 | - | $12.04 M(-16.6%) |
| Mar 2024 | - | $14.44 M(+5.1%) |
| Dec 2023 | $13.73 M(-11.5%) | $13.73 M(+17.0%) |
| Sep 2023 | - | $11.73 M(-12.6%) |
| Jun 2023 | - | $13.42 M(-13.5%) |
| Mar 2023 | - | $15.51 M(-0.0%) |
| Dec 2022 | $15.52 M(+211.4%) | $15.52 M(+23.6%) |
| Sep 2022 | - | $12.55 M(+3.0%) |
| Jun 2022 | - | $12.19 M(+14.1%) |
| Mar 2022 | - | $10.68 M(+114.4%) |
| Dec 2021 | $4.98 M(-59.6%) | $4.98 M(-6.3%) |
| Sep 2021 | - | $5.32 M(+25.5%) |
| Jun 2021 | - | $4.24 M(-29.0%) |
| Mar 2021 | - | $5.97 M(-51.6%) |
| Dec 2020 | $12.34 M(+133.2%) | $12.34 M(+192.4%) |
| Sep 2020 | - | $4.22 M(-2.5%) |
| Jun 2020 | - | $4.33 M(+19.0%) |
| Mar 2020 | - | $3.63 M(-31.3%) |
| Dec 2019 | $5.29 M(-11.4%) | $5.29 M(-5.1%) |
| Sep 2019 | - | $5.57 M(+3.2%) |
| Jun 2019 | - | $5.40 M(-7.0%) |
| Mar 2019 | - | $5.80 M(-2.8%) |
| Dec 2018 | $5.97 M(-75.7%) | $5.97 M(-50.2%) |
| Sep 2018 | - | $12.00 M(-51.7%) |
| Jun 2018 | - | $24.85 M(-3.5%) |
| Mar 2018 | - | $25.75 M(+4.8%) |
| Dec 2017 | $24.57 M(+326.7%) | $24.57 M(-12.3%) |
| Sep 2017 | - | $28.02 M(-18.9%) |
| Jun 2017 | - | $34.54 M(-4.8%) |
| Mar 2017 | - | $36.27 M(+529.9%) |
| Dec 2016 | $5.76 M(-89.9%) | $5.76 M(-86.5%) |
| Sep 2016 | - | $42.54 M(-9.9%) |
| Jun 2016 | - | $47.22 M(+11.8%) |
| Mar 2016 | - | $42.22 M(-26.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $57.07 M(+109.6%) | $57.07 M(+53.9%) |
| Sep 2015 | - | $37.09 M(-2.7%) |
| Jun 2015 | - | $38.11 M(+12.2%) |
| Mar 2015 | - | $33.96 M(+24.7%) |
| Dec 2014 | $27.23 M(-56.4%) | $27.23 M(-13.8%) |
| Sep 2014 | - | $31.59 M(-5.5%) |
| Jun 2014 | - | $33.41 M(+24.5%) |
| Mar 2014 | - | $26.84 M(-57.0%) |
| Dec 2013 | $62.47 M(+292.4%) | $62.47 M(+71.1%) |
| Sep 2013 | - | $36.51 M(+41.8%) |
| Jun 2013 | - | $25.75 M(-2.4%) |
| Mar 2013 | - | $26.38 M(+65.7%) |
| Dec 2012 | $15.92 M(+42.1%) | $15.92 M(+58.3%) |
| Sep 2012 | - | $10.06 M(+7.9%) |
| Jun 2012 | - | $9.32 M(-66.0%) |
| Mar 2012 | - | $27.39 M(+144.5%) |
| Dec 2011 | $11.20 M(+122.9%) | $11.20 M(-47.8%) |
| Sep 2011 | - | $21.46 M(+27.6%) |
| Jun 2011 | - | $16.82 M(+95.2%) |
| Mar 2011 | - | $8.62 M(+71.4%) |
| Dec 2010 | $5.03 M(-8.2%) | $5.03 M(-19.9%) |
| Sep 2010 | - | $6.27 M(+16.8%) |
| Jun 2010 | - | $5.37 M(-38.9%) |
| Mar 2010 | - | $8.80 M(+60.7%) |
| Dec 2009 | $5.47 M(+294.7%) | $5.47 M(+40.3%) |
| Sep 2009 | - | $3.90 M(+108.9%) |
| Jun 2009 | - | $1.87 M(+25.2%) |
| Mar 2009 | - | $1.49 M(+7.6%) |
| Dec 2008 | $1.39 M(+4.8%) | $1.39 M(+17.5%) |
| Sep 2008 | - | $1.18 M(-22.5%) |
| Jun 2008 | - | $1.52 M(-14.2%) |
| Mar 2008 | - | $1.77 M(+34.0%) |
| Dec 2007 | $1.32 M(>+9900.0%) | $1.32 M(-22.7%) |
| Sep 2007 | - | $1.71 M(>+9900.0%) |
| Dec 2006 | $0.00 | $0.00 |
FAQ
- What is SELLAS Life Sciences annual total current liabilities?
- What is the all time high annual current liabilities for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual current liabilities year-on-year change?
- What is SELLAS Life Sciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly current liabilities year-on-year change?
What is SELLAS Life Sciences annual total current liabilities?
The current annual current liabilities of SLS is $13.73 M
What is the all time high annual current liabilities for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual total current liabilities is $62.47 M
What is SELLAS Life Sciences annual current liabilities year-on-year change?
Over the past year, SLS annual total current liabilities has changed by -$1.78 M (-11.47%)
What is SELLAS Life Sciences quarterly total current liabilities?
The current quarterly current liabilities of SLS is $10.61 M
What is the all time high quarterly current liabilities for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly total current liabilities is $62.47 M
What is SELLAS Life Sciences quarterly current liabilities year-on-year change?
Over the past year, SLS quarterly total current liabilities has changed by -$3.12 M (-22.73%)